查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1625408

对乙酰氨基酚静脉注射市场规模、占有率、趋势、行业分析报告（按适应症、应用、最终用途和地区）- 市场预测，2025-2034 年

Paracetamol IV Market Size, Share, Trends, Industry Analysis Report: By Indication (Pain and Pyrexia), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，静脉注射对乙酰氨基酚市场规模预计到 2034 年将达到 11.1785 亿美元。该研究报告对当前市场动态提供了详细的见解，并对未来市场成长进行了分析。

静脉注射对乙酰氨基酚市场的扩张是由对有效疼痛管理解决方案的不断增长的需求推动的，特别是在快速起效至关重要的临床环境中。市场需求很大程度上是由人们对静脉注射製剂而非口服製剂的偏好所支持的，尤其是对于口服给药困难的患者而言。外科手术增多、需要术后止痛的慢性病发生率增加、老年人口不断增加等因素促使静脉注射对乙酰氨基酚的需求不断增加。全球医疗保健基础设施的扩张极大地推动了静脉注射对乙酰氨基酚市场的成长。

静脉注射对乙酰氨基酚市场的前景无疑是光明的，药物输送方面的突破性创新和配方技术的改进提供了巨大的市场机会，确保对乙酰氨基酚的静脉注射对不同患者群体更安全、更有效。此外，静脉注射对乙酰氨基酚市场的扩张得到了领先产业参与者对研发的策略投资的支持。这些投资主要集中在最大程度提高产品的功效和安全性，同时最大程度减少副作用，巩固静脉注射对乙酰氨基酚作为疼痛管理方案中更好选择的地位。

对乙酰氨基酚静脉注射市场报告重点

在 2024 年的对乙酰氨基酚静脉注射市场中，由于对手术和创伤后有效和立即缓解疼痛的需求很高，预计疼痛部分将占据主要占有率（基于适应症）。

根据最终用途，诊所部分预计将在预测期内实现最高的复合年增长率，这归因于人们对门诊护理的偏好日益增加以及诊所中静脉疼痛管理选项的可用性不断增加。

由于整个地区都重视有效的疼痛管理，到 2024 年，北美将占据静脉注射对乙酰氨基酚市场的主导地位。

由于医疗保健投资的增加，预计亚太市场在预测期内将显着成长。

全球市场的主要参与者包括 Mallinckrodt（Mallinckrodt Pharmaceuticals）、Cipla Inc.、Lupin、Dr Reddy's Laboratories Ltd.、Aurobindo Pharma、Sun Pharmaceutical Industries Limited、Novartis AG、Pfizer Inc.、Abbott、Sanofi、Bristol-Myers Squibb Company 等。

目录

第 1 章简介

第 2 章执行摘要

第 3 章 研究方法

第 4 章。
  • 市场概况
  • 对乙酰氨基酚静脉注射剂市场动态
    • 推动因素和机遇
      • 手术程序增加
      • 慢性疼痛和发烧加剧
    • 阻碍因素和课题
      • 替代药物选择
  • PESTEL 分析
  • 对乙酰氨基酚静脉注射剂市场趋势
  • 价值链分析
  • COVID-19 影响分析

5. 全球静脉注射对乙酰氨基酚市场（依适应症划分）

  • 主要发现
  • 简介
  • 痛苦
  • 发烧

6. 全球对乙酰氨基酚注射剂市场（依应用）

  • 主要发现
  • 简介
  • 手术
  • 非手术

7. 全球静脉注射对乙酰氨基酚市场（依最终用途划分）

  • 主要发现
  • 简介
  • 医院
  • 诊所
  • 其他

8. 全球静脉注射对乙酰氨基酚市场（按地区）

  • 主要发现
  • 简介
    • 2020 年至 2034 年对乙酰氨基酚静脉注射剂市场各地区评估
  • 北美洲
    • 北美，依适应症分类，2020 年至 2034 年
    • 2020 年至 2034 年北美各应用领域
    • 2020 年至 2034 年，北美以最终用途划分
    • 美国
    • 加拿大
  • 欧洲
      2020 年至 2034 年欧洲各适应症 2020 年至 2034 年欧洲应用状况 2020 年至 2034 年欧洲最终用途状况
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲国家
    亚太地区
      亚太地区，依适应症，2020 年至 2034 年 2020 年至 2034 年亚太地区应用情况 2020 年至 2034 年亚太地区最终用途
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲
      2020 年至 2034 年中东及非洲各指标 2020 年至 2034 年中东和非洲的应用状况
    • 2020 年至 2034 年中东和非洲依最终用途划分
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲地区
  • 拉丁美洲
    • 2020 年至 2034 年拉丁美洲依适应症划分的情况
    • 2020 年至 2034 年拉丁美洲各应用领域状况
    • 2020 年至 2034 年拉丁美洲依最终用途划分
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲国家

第 9 章 竞争格局

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协定/揭露

第十章 公司简介

  • Mallinckrodt（Mallinckrodt Pharmaceuticals）
  • Cipla Inc.
  • Lupin
  • Dr Reddy's Laboratories Ltd.
  • Aurobindo Pharma
  • Sun Pharmaceutical Industries Limited
  • Novartis AG
  • Pfizer Inc.
  • Abbott
  • Sanofi
  • Bristol-Myers Squibb Company
Product Code: PM5289

The paracetamol IV market size is expected to reach USD 1,117.85 million by 2034, according to a new study by Polaris Market Research. The report "Paracetamol IV Market Share, Size, Trends, Industry Analysis Report: By Indication (Pain and Pyrexia), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising demand for effective pain management solutions, particularly in clinical settings where rapid onset is crucial, drives the paracetamol IV market expansion. The preference for intravenous (IV) formulations over oral routes, especially for patients unable to take medication orally, significantly supports market demand. Factors such as increasing surgical procedures, a growing prevalence of chronic conditions requiring postoperative pain relief, and the expanding geriatric population contribute to the rising need for paracetamol IV formulations. The global expansion of healthcare infrastructure is significantly propelling the paracetamol IV market growth, as more hospitals and clinics are becoming equipped to provide IV pain management.

The paracetamol IV market outlook is undeniably positive, with significant market opportunities fueled by groundbreaking innovations in drug delivery and enhanced formulation techniques that ensure intravenous (IV) paracetamol is both safer and more effective for diverse patient groups. Furthermore, the IV paracetamol market expansion is supported by strategic investments in research and development from leading industry players. These investments are specifically geared toward maximizing product efficacy and safety while minimizing side effects, firmly establishing IV paracetamol as a better option in pain management protocols.

Paracetamol IV Market Report Highlights

In terms of indication, in 2024, the pain segment accounted for a larger share of the paracetamol IV market revenue due to the high demand for effective and immediate pain relief in post-surgical and trauma cases.

The clinics segment, based on end use, is expected to witness the highest CAGR during the forecast period due to the growing preference for outpatient care and the increasing availability of intravenous pain management options in clinic settings.

In 2024, North America dominated the paracetamol IV market share due to the strong focus on effective pain management practices across the region.

The Asia Pacific market is expected to witness significant growth during the forecast period due to increasing healthcare investments.

A few global key market players are Mallinckrodt (Mallinckrodt Pharmaceuticals), Cipla Inc., Lupin, Dr Reddy's Laboratories Ltd., Aurobindo Pharma, Sun Pharmaceutical Industries Limited, Novartis AG, Pfizer Inc., Abbott, Sanofi, and Bristol-Myers Squibb Company.

Polaris Market Research has segmented the paracetamol IV market report on the basis of indication, application, end use, and region:

By Indication Outlook (Revenue, USD Million; 2020-2034)

  • Pain
  • Pyrexia

By Application Outlook (Revenue, USD Million; 2020-2034)

  • Surgical
  • Non-Surgical

By End Use Outlook (Revenue, USD Million; 2020-2034)

  • Hospitals
  • Clinics
  • Others

By Regional Outlook (Revenue, USD Million; 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Paracetamol IV Market Insights

  • 4.1. Paracetamol IV Market - Market Snapshot
  • 4.2. Paracetamol IV Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Surgical Procedures
      • 4.2.1.2. Rising Prevalence of Chronic Pain and Fever
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Alternative Drug Option
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Paracetamol IV Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Paracetamol IV Market, by Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
  • 5.3. Pain
    • 5.3.1. Global Paracetamol IV Market, by Pain, by Region, 2020-2034 (USD Million)
  • 5.4. Pyrexia
    • 5.4.1. Global Paracetamol IV Market, by Pyrexia, by Region, 2020-2034 (USD Million)

6. Global Paracetamol IV Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Paracetamol IV Market, by Application, 2020-2034 (USD Million)
  • 6.3. Surgical
    • 6.3.1. Global Paracetamol IV Market, by Surgical, by Region, 2020-2034 (USD Million)
  • 6.4. Non-surgical
    • 6.4.1. Global Paracetamol IV Market, by Non-surgical, by Region, 2020-2034 (USD Million)

7. Global Paracetamol IV Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
  • 7.3. Hospital
    • 7.3.1. Global Paracetamol IV Market, by Hospital, by Region, 2020-2034 (USD Million)
  • 7.4. Clinics
    • 7.4.1. Global Paracetamol IV Market, by Clinics, by Region, 2020-2034 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Paracetamol IV Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Paracetamol IV Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Paracetamol IV Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Paracetamol IV Market - North America
    • 8.3.1. North America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
    • 8.3.2. North America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
    • 8.3.3. North America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.3.4. Paracetamol IV Market - U.S.
      • 8.3.4.1. U.S.: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.3.4.2. U.S.: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.3.4.3. U.S.: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.3.5. Paracetamol IV Market - Canada
      • 8.3.5.1. Canada: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
  • 8.4. Paracetamol IV Market - Europe
    • 8.4.1. Europe: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
    • 8.4.2. Europe: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
    • 8.4.3. Europe: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.4. Paracetamol IV Market - UK
      • 8.4.4.1. UK: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.5. Paracetamol IV Market - France
      • 8.4.5.1. France: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.5.2. France: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.5.3. France: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.6. Paracetamol IV Market - Germany
      • 8.4.6.1. Germany: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.7. Paracetamol IV Market - Italy
      • 8.4.7.1. Italy: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.8. Paracetamol IV Market - Spain
      • 8.4.8.1. Spain: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.9. Paracetamol IV Market - Netherlands
      • 8.4.9.1. Netherlands: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.10. Paracetamol IV Market - Russia
      • 8.4.10.1. Russia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.4.11. Paracetamol IV Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
  • 8.5. Paracetamol IV Market - Asia Pacific
    • 8.5.1. Asia Pacific: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.4. Paracetamol IV Market - China
      • 8.5.4.1. China: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.4.2. China: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.4.3. China: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.5. Paracetamol IV Market - India
      • 8.5.5.1. India: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.5.2. India: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.5.3. India: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.6. Paracetamol IV Market - Malaysia
      • 8.5.6.1. Malaysia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.7. Paracetamol IV Market - Japan
      • 8.5.7.1. Japan: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.8. Paracetamol IV Market - Indonesia
      • 8.5.8.1. Indonesia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.9. Paracetamol IV Market - South Korea
      • 8.5.9.1. South Korea: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.10. Paracetamol IV Market - Australia
      • 8.5.10.1. Australia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.5.11. Paracetamol IV Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
  • 8.6. Paracetamol IV Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.6.4. Paracetamol IV Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.6.5. Paracetamol IV Market - UAE
      • 8.6.5.1. UAE: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.6.6. Paracetamol IV Market - Israel
      • 8.6.6.1. Israel: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.6.7. Paracetamol IV Market - South Africa
      • 8.6.7.1. South Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.6.8. Paracetamol IV Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
  • 8.7. Paracetamol IV Market - Latin America
    • 8.7.1. Latin America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.7.4. Paracetamol IV Market - Mexico
      • 8.7.4.1. Mexico: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.7.5. Paracetamol IV Market - Brazil
      • 8.7.5.1. Brazil: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.7.6. Paracetamol IV Market - Argentina
      • 8.7.6.1. Argentina: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)
    • 8.7.7. Paracetamol IV Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Mallinckrodt (Mallinckrodt Pharmaceuticals)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Cipla Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Lupin
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Dr Reddy's Laboratories Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Aurobindo Pharma
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Sun Pharmaceutical Industries Limited
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Novartis AG
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Pfizer Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Abbott
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sanofi
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Bristol-Myers Squibb Company
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables:

Table 1 Global Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 2 Global Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 3 Global Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 4 North America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 5 North America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 6 North America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 7 U.S.: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 8 U.S.: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 9 U.S.: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 10 Canada: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 11 Canada: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 12 Canada: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 13 Europe: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 14 Europe: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 15 Europe: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 16 UK: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 17 UK: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 18 UK: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 19 France: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 20 France: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 21 France: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 22 Germany: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 23 Germany: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 24 Germany: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 25 Italy: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 26 Italy: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 27 Italy: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 28 Spain: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 29 Spain: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 30 Spain: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 31 Netherlands: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 32 Netherlands: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 33 Netherlands: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 34 Russia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 35 Russia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 36 Russia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 37 Rest of Europe: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 38 Rest of Europe: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 39 Rest of Europe: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 40 Asia Pacific: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 41 Asia Pacific: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 42 Asia Pacific: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 43 China: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 44 China: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 45 China: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 46 India: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 47 India: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 48 India: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 49 Malaysia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 50 Malaysia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 51 Malaysia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 52 Japan: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 53 Japan: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 54 Japan: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 55 Indonesia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 56 Indonesia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 57 Indonesia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 58 South Korea: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 59 South Korea: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 60 South Korea: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 61 Australia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 62 Australia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 63 Australia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 64 Rest of Asia Pacific: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 65 Rest of Asia Pacific: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 66 Rest of Asia Pacific: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 67 Middle East & Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 68 Middle East & Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 69 Middle East & Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 70 Saudi Arabia: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 71 Saudi Arabia: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 72 Saudi Arabia: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 73 UAE: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 74 UAE: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 75 UAE: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 76 Israel: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 77 Israel: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 78 Israel: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 79 South Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 80 South Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 81 South Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 82 Rest of Middle East & Africa: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 83 Rest of Middle East & Africa: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 84 Rest of Middle East & Africa: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 85 Latin America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 86 Latin America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 87 Latin America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 88 Mexico: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 89 Mexico: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 90 Mexico: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 91 Brazil: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 92 Brazil: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 93 Brazil: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 94 Argentina: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 95 Argentina: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 96 Argentina: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

Table 97 Rest of Latin America: Paracetamol IV Market, by Indication, 2020-2034 (USD Million)

Table 98 Rest of Latin America: Paracetamol IV Market, by Application, 2020-2034 (USD Million)

Table 99 Rest of Latin America: Paracetamol IV Market, by End Use, 2020-2034 (USD Million)

List of Figures:

Figure 1. Global Paracetamol IV Market, 2020-2034 (USD Million)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Price

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Indication

Figure 7. Global Paracetamol IV Market, by Indication, 2024 & 2034 (USD Million)

Figure 8. Market by Application

Figure 9. Global Paracetamol IV Market, by Application, 2024 & 2034 (USD Million)

Figure 10. Market by End Use

Figure 11. Global Paracetamol IV Market, by End Use, 2024 & 2034 (USD Million)